Center for Health Research–Southeast, Kaiser Permanente, 11 Piedmont Center, 3495 Piedmont Rd NE, Suite 110, Atlanta, GA 30305, USA.
Clin Infect Dis. 2013 May;56(9):1216-22. doi: 10.1093/cid/cit045. Epub 2013 Feb 1.
Influenza infection during pregnancy is associated with adverse fetal outcomes such as preterm birth and small for gestational age (SGA). Maternal influenza immunization may prevent these adverse infant outcomes during periods of influenza circulation.
We conducted a retrospective cohort study of live births within Kaiser Permanente (KP) Georgia and Mid-Atlantic States (n = 3327) during the period of 2009 influenza A (H1N1) virus circulation. Primary outcomes were third-trimester preterm birth (27-36 weeks), birth weight, low birth weight (LBW, <2500 g), and SGA.
There were 327 (9.8%) preterm, 236 (7.4%) LBW, and 267 (8.4%) SGA births. Among H1N1-vaccinated mothers (n = 1125), there were 86 (7.6%) preterm, 68 (6.4%) LBW, and 99 (9.3%) SGA births, and the mean birth weight was 3308.5 g (95% confidence interval [CI], 3276.6-3340.4). Among unvaccinated mothers (n = 1581), there were 191 (12.1%) preterm, 132 (8.8%) LBW, and 123 (8.2%) SGA births, and the mean birth weight was 3245.3 g (95% CI, 3216.5-3274.2). Infants of H1N1-vaccinated mothers had 37% lower odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI, .47-.84]). The mean birth weight difference between infants of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3). There was no significant association between maternal H1N1 influenza immunization and LBW or SGA.
Pregnant women who received H1N1 influenza vaccine were less likely to give birth preterm, and gave birth to heavier infants. The findings support US vaccine policy choices to prioritize pregnant women during the 2009 influenza A (H1N1) pandemic.
流感感染在怀孕期间与不良胎儿结局相关,如早产和小于胎龄儿(SGA)。母亲流感免疫接种可能会在流感流行期间预防这些不良婴儿结局。
我们对 2009 年甲型 H1N1 流感病毒流行期间在凯撒永久医疗集团(Kaiser Permanente,KP)佐治亚州和中大西洋州的活产儿(n=3327)进行了回顾性队列研究。主要结局是第三孕期早产(27-36 周)、出生体重、低出生体重(LBW,<2500g)和 SGA。
有 327 例(9.8%)早产、236 例(7.4%)LBW 和 267 例(8.4%)SGA 出生。在 H1N1 疫苗接种母亲中(n=1125),有 86 例(7.6%)早产、68 例(6.4%)LBW 和 99 例(9.3%)SGA 出生,平均出生体重为 3308.5g(95%可信区间[CI],3276.6-3340.4)。在未接种疫苗的母亲中(n=1581),有 191 例(12.1%)早产、132 例(8.8%)LBW 和 123 例(8.2%)SGA 出生,平均出生体重为 3245.3g(95%CI,3216.5-3274.2)。接种 H1N1 疫苗的母亲所生婴儿早产的可能性比未接种疫苗的母亲所生婴儿低 37%(调整后的优势比,0.63[95%CI,0.47-0.84])。接种 H1N1 疫苗的母亲所生婴儿与未接种疫苗的母亲所生婴儿的平均出生体重差异为 45.1g(95%CI,1.8-88.3)。母亲接种 H1N1 流感疫苗与 LBW 或 SGA 之间无显著关联。
接受 H1N1 流感疫苗的孕妇早产的可能性较低,所生婴儿体重也较重。这些发现支持美国在 2009 年甲型 H1N1 流感大流行期间将孕妇列为疫苗接种优先人群的疫苗政策选择。